Independent Data Monitoring Committee Reviews Marshall Edwards, Inc.'s Arrangements for Data Analysis of the Ovature Trial
June 17, 2009 08:30 ET
|
Marshall Edwards, Inc.
NEW CANAAN, CT--(Marketwire - June 17, 2009) - The Independent Data Monitoring Committee
(IDMC) created to oversee the conduct of the Phase III OVArian TUmor
REsponse (OVATURE) Trial, which convened...
Novogen's NV-128 Targets the mTOR Pathway to Block Differentiation and Induce Cell Death in Ovarian Cancer Stem Cells
April 20, 2009 08:00 ET
|
Novogen, Limited
NEW CANAAN, CT and SYDNEY, AUSTRALIA--(Marketwire - April 20, 2009) - Data presented
yesterday at the Annual Meeting of the American Association for Cancer
Research in Denver has demonstrated that...
Marshall Edwards, Inc., to Undertake Analysis of Ovature Trial
April 14, 2009 08:20 ET
|
Marshall Edwards, Inc.
NEW CANAAN, CT and SYDNEY, AUSTRALIA--(Marketwire - April 14, 2009) - Marshall Edwards,
Inc., (NASDAQ: MSHL) today announced that it will be undertaking an
un-blinded analysis of the data from its...
Board Changes at Novogen Limited Announced
March 23, 2009 10:46 ET
|
Novogen, Limited
NEW CANAAN, CT and SYDNEY, AUSTRALIA--(Marketwire - March 23, 2009) - Novogen Limited (ASX: NRT) (NASDAQ: NVGN) is pleased to announce the appointment of Mr. William
D. Rueckert to its Board of...
Biotech Analyst Joins Board of Directors of Marshall Edwards, Inc.
March 19, 2009 13:07 ET
|
Marshall Edwards, Inc.
NEW CANAAN, CT and SYDNEY, AUSTRALIA--(Marketwire - March 19, 2009) - Marshall Edwards, Inc.
(NASDAQ: MSHL) is pleased to announce the appointment of Leah Cann to the
Board of Directors of the...
Marshall Edwards, Inc. Granted IND for Triphendiol
January 07, 2009 08:10 ET
|
Marshall Edwards, Inc.
NEW CANAAN, CT--(Marketwire - January 7, 2009) - Marshall Edwards, Inc. (NASDAQ: MSHL) today
announced that it has been granted an Investigative New Drug (IND) approval
by the United States Food and...
Marshall Edwards, Inc. Announces Resignation of Stephen Breckenridge From Board of Directors and Appointment of William Rueckert as Chairman of Audit Committee
December 19, 2008 08:15 ET
|
Marshall Edwards, Inc.
NEW CANAAN, CT--(Marketwire - December 19, 2008) - Marshall Edwards, Inc. (NASDAQ: MSHL)
announced that Stephen Breckenridge resigned as a member of the Board of
Directors effective December 15, 2008...
Independent Data Monitoring Committee Recommends Marshall Edwards, Inc.'s OVATURE Trial Continue
November 13, 2008 08:10 ET
|
Novogen, Limited
NEW CANAAN, CT--(Marketwire - November 13, 2008) - The Independent Data Monitoring Committee
(IDMC) constituted to oversee the conduct of the Phase III OVArian TUmor
REsponse (OVATURE) Trial,...
Independent Data Monitoring Committee Recommends Marshall Edwards, Inc.'s OVATURE Trial Continue
November 12, 2008 08:10 ET
|
Marshall Edwards, Inc.
NEW CANAAN, CT--(Marketwire - November 12, 2008) - The Independent Data Monitoring Committee
(IDMC) constituted to oversee the conduct of the Phase III OVArian TUmor
REsponse (OVATURE) Trial,...
Marshall Edwards, Inc.'s Investigational Drug Triphendiol (NV-196) Demonstrates Potent Activity Against Biliary Cancers
April 13, 2008 16:00 ET
|
Marshall Edwards, Inc.
SAN DIEGO, CA--(Marketwire - April 13, 2008) - Pre-clinical studies presented here today at
the annual meeting of the American Association for Cancer Research
demonstrate that Marshall Edwards,...